Where does Diagnostic BioSystems rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Diagnostic BioSystems ranks #31,398 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Diagnostic BioSystems hold?

Diagnostic BioSystems holds 8 US utility patents granted between 2019 and 2024, spanning 7 technology areas.

What is Diagnostic BioSystems's Innovation Score?

Diagnostic BioSystems has an Innovation Score of 25.3 out of 100 (17th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Diagnostic BioSystems focus on?

Diagnostic BioSystems's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 8 patents, ranking #1,791 of 7,863 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Diagnostic BioSystems's patent grant rate increasing or decreasing?

Diagnostic BioSystems's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Diagnostic BioSystems's patents?

Diagnostic BioSystems's patents average 10.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Diagnostic BioSystems patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Diagnostic BioSystems

USPTO PatentsView assignee record - 8 granted patents across 7 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Diagnostic ranks #31,398 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 7 technology areas.

#31,398
of 49,997 US assignees by volume: 17th percentile
by Innovation Score (25.3/100): 10.3
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31398 · US Corporation #31,398 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #31,398/49,997
PHOTO-FINISH Deuteria Beverages
CPC-NARROW G01N · 7 areas
INNOV-THIN 25.3/100
CLAIMS-PAR 10.3 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Deuteria Beverages, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Diagnostic’s 25.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (30%) Velocity 2.2 pts (9%) Breadth 9.4 pts (37%) Claim depth 6.1 pts (24%)

Qualcomm Incorporated · highest

85
Hunkeler · near

25
Diagnostic BioSystems · this assignee

25
Fugenbio · near

25
Native Instruments · near

25
Smeg S P A · near

25
3D Lighting… · lowest

7

What this shows Diagnostic's Innovation Score is 25.3/100 (17th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Diagnostic?

Each dot is one of Diagnostic’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Diagnostic’s own 10.3 claims/patent is at or below the 18.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Diagnostic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Diagnostic's grants concentrate

Diagnostic BioSystems is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2023. By volume, Diagnostic sits between Deuteria Beverages, LLC and Digital Aerolus, Inc..

Diagnostic's three-year grant acceleration

Diagnostic BioSystems shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Deuteria Beverages

8
Devmar Products

8
Devicescape Softw…

8
Dextera Surgical

8
Diagnostics for t…

8
Diem

8
Digger Specialties

8
Digital Aerolus

8
Diagnostic Biosys… ◀

8

What this shows Diagnostic holds 8 patents at rank #31,444, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Diagnostic

By rank, the assignees closest to #31,444 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Diagnostic's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Diagnostic, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Diagnostic ranks #1,791 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (25 here).

Native Instruments GMBH 25 Fugenbio Co., Ltd. 25 Smeg S.P.A. 25 Hunkeler AG 25

Diagnostic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 17th percentile higher than 17% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Diagnostic BioSystems patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	4	50.0%
2020	2	25.0%
2023	1	12.5%
2024	1	12.5%

Which technologies does Diagnostic BioSystems patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

G02B - Optical Elements, Systems OR Apparatus 1

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 1

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 1

C08L - Compositions OF Macromolecular Compounds 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Diagnostic BioSystems's patent record in context - here's where to go next.

Diagnostic BioSystems's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 100% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #31,398 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Diagnostic BioSystems against Deuteria Beverages, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.